Haisco Pharmaceutical Group Co., Ltd. (stock symbol: 002653) based in Beijing shared news on June 23, 2026, regarding an exclusive licensing deal with Nuvectis, a biotech firm in the U.S. This agreement entails various terms and grants Haisco specific rights.